WebApr 10, 2024 · Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging …
Did you know?
WebDec 20, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers ... WebMar 15, 2024 · Statera Biopharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.
WebApr 27, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers ... WebOct 6, 2024 · FORT COLLINS, Colo., Sept. 2, 2024 /PRNewswire/ -- Statera BioPharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune …
WebMar 6, 2024 · All news about STATERA BIOPHARMA, INC. 02/01: Statera Biopharma, Inc. : Material Modification to Rights of Security Holders, Amendments .. AQ. 01/20: Statera Biopharma, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Ru.. AQ. 01/17: Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI I.. CI. WebFeb 6, 2024 · About Statera Biopharma. Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore …
WebApr 12, 2024 · A high-level overview of Statera Biopharma, Inc. (STAB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebStock analysis for Statera Biopharma Inc (CBLI) including stock price, stock chart, company news, key statistics, fundamentals and company profile. donate packaged underwearWebApr 10, 2024 · Subsequent to the merger, CBLI adopted a new corporate name, "Statera BioPharma, Inc.", with the ticker symbol "STAB," effective on September 1, 2024 ("Statera"). Statera emerged as a publicly traded entity following the merger with CBLI. ... More news: Financials (USD) Sales 2024---Net income 2024-3,54 M--Net Debt 2024: 0,55 M--P/E ratio … donate overlay youtubeWebStatera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging … city of burbank animal shelterWebNews See All News About Key Executives Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is... city of bunbury tendersWebDec 29, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and... city of burbank building and safetyWebStatera Biopharma, Inc. Morningstar A Weekly Summary of Stock Ideas and Developments in the Companies We Cover In this edition, railroads may be in for a bumpy ride; ESG has … donate ossoff georgiaWebStatera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. city of burbank building inspection